EGU26-16575, updated on 14 Mar 2026
https://doi.org/10.5194/egusphere-egu26-16575
EGU General Assembly 2026
© Author(s) 2026. This work is distributed under
the Creative Commons Attribution 4.0 License.
Poster | Wednesday, 06 May, 14:00–15:45 (CEST), Display time Wednesday, 06 May, 14:00–18:00
 
Hall X4, X4.46
Integrating Health Co-benefits into Climate Mitigation Policymaking
Jianxiang Shen1 and Wenjia Cai2
Jianxiang Shen and Wenjia Cai
  • 1Department of Earth System Science, Tsinghua University, Beijing, China (jxshen98@outlook.com)
  • 2Department of Earth System Science, Tsinghua University, Beijing, China (wcai@tsinghua.edu.cn)

Climate change mitigation can save lives and improve health through multiple pathways, such as reducing air pollution, promoting active transport, and facilitating healthier diets. These immediate health co-benefits can provide stronger incentives for climate action beyond mitigating health risks associated with global warming and extreme weather events. Thus, a comprehensive stocktake of mitigation costs, health co-benefits, and their consequent cost-effectiveness is critical to better prioritize health gains while achieving Nationally Determined Contribution (NDC) goals. This study first synthesizes findings on mitigation costs, health co-benefits, and cost-effectiveness of climate actions from global and regional health-included Cost-Benefit Analysis (CBA) studies. It then conducts an in-depth analysis of challenges in designing and implementing health-considered climate policies in real-world contexts, and finally proposes strategies for the scientific community to advance health-considered or even health-centered mitigation targets, technology pathways, and implementation strategies.

Global evidence indicates that air pollution-related health co-benefits of climate policies usually outweigh mitigation costs, with Benefit/Cost Ratios (BCRs) ranging from 1.10 to 2.45, meaning each $1 invested in mitigation yields $1.10~2.45 in health co-benefits (Figure 1). Notably, regional BCRs vary by up to 40-fold. Regions with high air pollution and population density (e.g., China and India) have greater health co-benefits, while developed regions (e.g., Europe, USA) with stringent pollution controls show lower co-benefits.

Figure 1 (a) Total carbon reductions (10 Mt), mitigation costs and health benefits (billion 2015 USD) from different original studies (n=332), and (b) regional distribution of annual BCR from different original studies.

Key recommendations include: (1) adopting policy-relevant methods (e.g., the Cost of Illness method, which incorporates tangible region-specific healthcare expenditure data to quantify the reduction of healthcare system burden) to monetize health co-benefits, replacing the Value of a Statistical Life (VSL)-based approaches; (2) fostering interdisciplinary collaboration (involving economists, political scientists, and sociologists alongside climate and health researchers) and strengthening cross-sector policy engagement, particularly engaging high-level decision-makers to establish interdepartmental collaboration frameworks that bridge fragmented governance; (3) conducting more national, subnational (especially in the Global South), or city-level localized studies and enhancing inter-study comparability through unified modeling frameworks and transparent data disclosure protocols (e.g., the Pathfinder Initiative, which integrates health impact data across pathways and regions); and (4) exploring health-optimized mitigation pathways (Figure 2) by addressing three core policy questions (i.e., target allocation across regions/sectors, optimal technology selection, and regionally tailored implementation), and incorporating health co-benefits into model objective functions to shift decision-making from traditional cost minimization to net benefit maximization. This work aims to provide actionable scientific guidance for integrating health co-benefits into climate mitigation modelling and policymaking, ultimately enhancing both climate and public health outcomes.

Figure 2 Conceptual framework for optimizing health-considered mitigation pathways. (a) 3 different research questions mentioned in the text. (b) Additional methods (in color red) to optimize climate policy with health co-benefits compared with current one-way assessment studies. (c) The mechanism of how the differentiated health benefits (in the color red) impact climate policymaking. (Source: Shen et al., Improving cost–benefit analyses for health-considered climate mitigation policymaking, Nature Climate Change, 2025)

How to cite: Shen, J. and Cai, W.: Integrating Health Co-benefits into Climate Mitigation Policymaking, EGU General Assembly 2026, Vienna, Austria, 3–8 May 2026, EGU26-16575, https://doi.org/10.5194/egusphere-egu26-16575, 2026.